{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T13:49:35Z","timestamp":1783777775021,"version":"3.55.0"},"reference-count":168,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Talanta"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.talanta.2020.121862","type":"journal-article","created":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T09:56:13Z","timestamp":1604570173000},"page":"121862","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"special_numbering":"C","title":["Detection and quantification of Covid-19 antiviral drugs in biological fluids and tissues"],"prefix":"10.1016","volume":"224","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6103-8860","authenticated-orcid":false,"given":"Maria A.","family":"Acquavia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9698-2007","authenticated-orcid":false,"given":"Luca","family":"Foti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaella","family":"Pascale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia","family":"Nicol\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0063-659X","authenticated-orcid":false,"given":"Vincenzo","family":"Brancaleone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommaso R.I.","family":"Cataldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Martelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3716-2666","authenticated-orcid":false,"given":"Laura","family":"Scrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9427-2274","authenticated-orcid":false,"given":"Giuliana","family":"Bianco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.talanta.2020.121862_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijantimicag.2020.105938","article-title":"New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?","volume":"55","author":"Devaux","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.talanta.2020.121862_bib2","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ijsu.2020.02.034","article-title":"A review of the 2019 novel coronavirus (COVID-19)","volume":"76","author":"Sohrabi","year":"2020","journal-title":"Int. J. Surg."},{"key":"10.1016\/j.talanta.2020.121862_bib3","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1021\/acsinfecdis.5b00030","article-title":"Evaluation of Ebola virus inhibitors for drug repurposing","volume":"1","author":"Madrid","year":"2016","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.talanta.2020.121862_bib4","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1001\/archderm.1980.01640290097026","article-title":"Antimalarial agents: chloroquine, hydroxychloroquine, and quinacrine","volume":"116","author":"Tanenbaum","year":"1980","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.talanta.2020.121862_bib5","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s40265-017-0723-3","article-title":"Baricitinib\u00a0: first global approval","volume":"77","author":"Markham","year":"2017","journal-title":"Drugs"},{"key":"10.1016\/j.talanta.2020.121862_bib6","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1056\/NEJMoa2001282","article-title":"A trial of lopinavir-ritonavir in adults hospitalized with severe covid-19","volume":"382","author":"Cao","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.talanta.2020.121862_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jia2.25489","article-title":"Systematic review of the efficacy and safety of antiretroviral drugs against SARS, MERS or COVID-19: initial assessment","volume":"23","author":"Ford","year":"2020","journal-title":"J. Int. AIDS Soc."},{"key":"10.1016\/j.talanta.2020.121862_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/0929867327666200416131117","article-title":"SARS CoV-2: recent reports on antiviral therapies based on lopinavir\/ritonavir, darunavir\/umifenovir, hydroxychloroquine, remdesivir, favipiravir and other drugs for the treatment of the new coronavirus","volume":"27","author":"Costanzo","year":"2020","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.talanta.2020.121862_bib9","doi-asserted-by":"crossref","first-page":"169","DOI":"10.4081\/monaldi.2020.1289","article-title":"Emerging prophylaxis strategies against COVID-19","volume":"90","author":"Agrawal","year":"2020","journal-title":"Monaldi Arch. Chest Dis."},{"key":"10.1016\/j.talanta.2020.121862_bib10","first-page":"1061","article-title":"Identification of FDA approved drugs targeting COVID-19 virus by structure- based drug repositioning","volume":"323","author":"Farag","year":"2020","journal-title":"JAMA, J. Am. Med. Assoc."},{"key":"10.1016\/j.talanta.2020.121862_bib11","first-page":"1","article-title":"Favipiravir: pharmacokinetics and concerns about clinical trials for 2019-nCoV infection","author":"Du","year":"2020","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.talanta.2020.121862_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.26633\/RPSP.2020.40","article-title":"Clinical trials on drug repositioning for COVID-19 treatment","volume":"44","author":"Rosa","year":"2020","journal-title":"Rev. Panam. Salud P\u00fablic"},{"key":"10.1016\/j.talanta.2020.121862_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117592","article-title":"Ribavirin, remdesivir, sofosbuvir, galidesivir, and tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): a molecular docking study","volume":"253","author":"Elfiky","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.talanta.2020.121862_bib14","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s40506-017-0130-z","article-title":"Discovering drugs for the treatment of Ebola virus","volume":"9","author":"Bixler","year":"2017","journal-title":"Curr. Treat. Options Infect. Dis."},{"key":"10.1016\/j.talanta.2020.121862_bib15","first-page":"1","article-title":"Novel coronavirus treatment with ribavirin: groundwork for an evaluation concerning COVID-19","author":"Khalili","year":"2020","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.talanta.2020.121862_bib16","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.tips.2020.03.006","article-title":"Ongoing clinical trials for the management of the COVID-19 pandemic","volume":"41","author":"Lythgoe","year":"2020","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.talanta.2020.121862_bib17","first-page":"2020","article-title":"Clinical outcomes and plasma concentrations of baloxavir marboxil and favipiravir in COVID-19 patients: an exploratory randomized, controlled trial","author":"Lou","year":"2020","journal-title":"MedRxiv"},{"key":"10.1016\/j.talanta.2020.121862_bib18","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in wuhan, China","volume":"323","author":"Wang","year":"2020","journal-title":"JAMA, J. Am. Med. Assoc."},{"key":"10.1016\/j.talanta.2020.121862_bib19","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.aca.2010.11.015","article-title":"Screening method for the analysis of antiviral drugs in poultry tissues using zwitterionic hydrophilic interaction liquid chromatography\/tandem mass spectrometry","volume":"700","author":"Chan","year":"2011","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.talanta.2020.121862_bib20","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jchromb.2016.04.036","article-title":"Simultaneous determination of 14 antiviral drugs and relevant metabolites in chicken muscle by UPLC-MS\/MS after QuEChERS preparation","volume":"1023","author":"Mu","year":"2016","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.talanta.2020.121862_bib21","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/mas.10050","article-title":"Quantitative high-throughput analysis of drugs in biological matrices by mass spectrometry","volume":"22","author":"Hopfgartner","year":"2003","journal-title":"Mass Spectrom. Rev."},{"key":"10.1016\/j.talanta.2020.121862_bib22","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.trac.2016.11.011","article-title":"Magnetic solid phase extraction for determination of drugs in biological matrices","volume":"89","author":"Vasconcelos","year":"2017","journal-title":"TrAC Trends Anal. Chem. (Reference Ed.)"},{"key":"10.1016\/j.talanta.2020.121862_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3904\/kjim.2009.24.1.1","article-title":"Overview of therapeutic drug monitoring","volume":"24","author":"Kang","year":"2009","journal-title":"Korean J. Intern. Med. (Korean Ed.)"},{"key":"10.1016\/j.talanta.2020.121862_bib24","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1007\/s00216-005-0253-9","article-title":"Development of restricted-access media supports and their application to the direct analysis of biological fluid samples via high-performance liquid chromatography","volume":"384","author":"Cassiano","year":"2006","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.talanta.2020.121862_bib25","first-page":"4","article-title":"Comparison of various international guidelines for analytical method validation","volume":"62","author":"Chandran","year":"2007","journal-title":"Die Pharm. Int. J. Pharm. Sci."},{"key":"10.1016\/j.talanta.2020.121862_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trac.2004.04.001","article-title":"Analytical method validation and quality assurance","volume":"23","author":"Taverniers","year":"2004","journal-title":"Trends Anal. Chem."},{"key":"10.1016\/j.talanta.2020.121862_bib27","doi-asserted-by":"crossref","first-page":"E43","DOI":"10.1208\/aapsj0901005","article-title":"The history of bioanalytical method validation and Regulation\u00a0: evolution of a guidance document on bioanalytical methods validation","volume":"9","author":"Shah","year":"2007","journal-title":"AAPS J."},{"key":"10.1016\/j.talanta.2020.121862_bib28","first-page":"1","article-title":"Bioanalytical method validation guidance","author":"Food and Drug Administration","year":"2018","journal-title":"Food Drug Adm"},{"key":"10.1016\/j.talanta.2020.121862_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4172\/2153-2435.1000288","article-title":"Bioanalytical method validation and its pharmaceutical application- A review","volume":"5","author":"V Sonawane","year":"2014","journal-title":"Pharm. Anal. Acta"},{"key":"10.1016\/j.talanta.2020.121862_bib30","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jchromb.2016.09.028","article-title":"Bioanalytical method development and validation: critical concepts and strategies","volume":"1043","author":"Moein","year":"2017","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.talanta.2020.121862_bib31","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1023\/A:1007669411738","article-title":"Bioanalytical method validation\u2014a revisit with a decade of progress","volume":"17","author":"Shah","year":"2000","journal-title":"Pharm. Res. (N. Y.)"},{"key":"10.1016\/j.talanta.2020.121862_bib32","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s10337-010-1869-2","article-title":"International guidelines for bioanalytical method validation: a comparison and discussion on current scenario","volume":"73","author":"Kollipara","year":"2011","journal-title":"Chromatographia"},{"key":"10.1016\/j.talanta.2020.121862_bib33","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1208\/aapsj0901011","article-title":"Anthony, Key elements of bioanalytical method validation for macromolecules","volume":"9","author":"Bansal","year":"2007","journal-title":"AAPS J."},{"key":"10.1016\/j.talanta.2020.121862_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/bmc.4270","article-title":"LC\u2013MS\/MS method for the simultaneous determination of tenofovir, emtricitabine, elvitegravir and rilpivirine in dried blood spots","volume":"32","author":"Prathipati","year":"2018","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.talanta.2020.121862_bib35","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/jms.3952","article-title":"Automated high throughput analysis of antiretroviral drugs in dried blood spots","volume":"52","author":"Duthaler","year":"2017","journal-title":"J. Mass Spectrom."},{"key":"10.1016\/j.talanta.2020.121862_bib36","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jchromb.2017.06.012","article-title":"Development, validation and clinical application of a method for the simultaneous quantification of lamivudine, emtricitabine and tenofovir in dried blood and dried breast milk spots using LC\u2013MS\/MS","volume":"1060","author":"Waitt","year":"2017","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.talanta.2020.121862_bib37","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1002\/bmc.3510","article-title":"Dried blood spot analysis of (+) and (-) darunavir enantiomers on immobilized amylose tris-(3, 5-dimethylphenylcarbamate) LC and its application to pharmacokinetics","volume":"29","author":"Nageswara Rao","year":"2015","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.talanta.2020.121862_bib38","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jchromb.2015.08.016","article-title":"Rat dried blood spot analysis of (R,S)-(-)- and (S,R)-(+)- enantiomers of emtricitabin on immobilized tris-(3,5-dimethylphenyl carbamate) amylose silica as a chiral stationary phase","volume":"1002","author":"Rao","year":"2015","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.talanta.2020.121862_bib39","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jchromb.2013.10.035","article-title":"Development and validation of a dried blood spot assay for the quantification of ribavirin using liquid chromatography coupled to mass spectrometry","volume":"944","author":"Jimmerson","year":"2014","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.talanta.2020.121862_bib40","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.jchromb.2014.05.008","article-title":"Parallel ultra high pressure liquid chromatography-mass spectrometry for the quantification of HIV protease inhibitors using dried spot sample collection format","volume":"965","author":"Watanabe","year":"2014","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.talanta.2020.121862_bib41","doi-asserted-by":"crossref","first-page":"3473","DOI":"10.1007\/s00216-011-5050-z","article-title":"Dried blood spot UHPLC-MS\/MS analysis of oseltamivir and oseltamivircarboxylate-a validated assay for the clinic","volume":"400","author":"Hooff","year":"2011","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.talanta.2020.121862_bib42","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jchromb.2016.08.011","article-title":"Development and validation of a LC\u2013MS\/MS method for the quantification of tenofovir and emtricitabine in seminal plasma","volume":"1033\u20131034","author":"Illamola","year":"2016","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.talanta.2020.121862_bib43","doi-asserted-by":"crossref","first-page":"839","DOI":"10.31788\/RJC.2019.1225118","article-title":"Stability indicating determination of darunavir with hplc in blood plasma samples","volume":"12","author":"Vanaja","year":"2019","journal-title":"Rasayan J. Chem."},{"key":"10.1016\/j.talanta.2020.121862_bib44","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/elan.201200437","article-title":"A new validated potentiometric method for batch and continuous quality control monitoring of oseltamivir phosphate (Taminil) in drug Formulations and biological fluids","volume":"25","author":"Hassan","year":"2013","journal-title":"Electroanalysis"},{"key":"10.1016\/j.talanta.2020.121862_bib45","first-page":"27735","article-title":"Development and validation of stability-indicating spectrofluorometric method for determination of H1N1 antiviral drug (Oseltamivir phosphate) in human plasma through Hantzsch reaction","volume":"5","author":"Omar","year":"2015","journal-title":"R. Soc. Chem. Adv."},{"key":"10.1016\/j.talanta.2020.121862_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/bmc.4158","article-title":"Simultaneous determination and validation of emtricitabine, rilpivirine and tenofovir from biological samples using LC and CE methods","volume":"32","author":"Gumustas","year":"2018","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.talanta.2020.121862_bib47","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jchromb.2018.03.045","article-title":"A LC\/MS\/MS method for determination of tenofovir in human plasma and its application to toxicity monitoring","volume":"1085","author":"Wiriyakosol","year":"2018","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.talanta.2020.121862_bib48","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.clinbiochem.2015.12.011","article-title":"Quantification of darunavir and etravirine in human peripheral blood mononuclear cells using high performance liquid chromatography tandem mass spectrometry (LC-MS\/MS), clinical application in a cohort of 110 HIV-1 infected patients and evidence of a pote","volume":"49","author":"Belkhir","year":"2016","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.talanta.2020.121862_bib49","doi-asserted-by":"crossref","first-page":"6682","DOI":"10.1128\/AAC.00869-15","article-title":"A simple, efficient, and sensitive method for simultaneous detection of anti-HIV drugs atazanavir, ritonavir, and tenofovir by use of liquid chromatography-tandem mass spectrometry","volume":"59","author":"Koehn","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.talanta.2020.121862_bib50","first-page":"8","year":"2002","journal-title":"Off. J. Eur. Communities"},{"key":"10.1016\/j.talanta.2020.121862_bib51","doi-asserted-by":"crossref","first-page":"865","DOI":"10.4155\/bio.12.44","article-title":"European medicines agency guideline on bioanalytical method validation: what more is there to say?","volume":"4","author":"Smith","year":"2012","journal-title":"Bioanalysis"},{"key":"10.1016\/j.talanta.2020.121862_bib52","series-title":"ICH Guideline M10 on Bioanalytical Method Validation","first-page":"1","year":"2019"},{"key":"10.1016\/j.talanta.2020.121862_bib53","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jbbm.2006.10.001","article-title":"Determination of drugs in biological fluids by direct injection of samples for liquid-chromatographic analysis","volume":"70","author":"Mullett","year":"2007","journal-title":"J. Biochem. Biophys. Methods"},{"key":"10.1016\/j.talanta.2020.121862_bib54","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S0165-9936(03)00402-3","article-title":"New trends in sample preparation for clinical and pharmaceutical analysis","volume":"22","author":"Kataoka","year":"2003","journal-title":"Trends Anal. Chem."},{"key":"10.1016\/j.talanta.2020.121862_bib55","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/0731-7085(89)80047-0","article-title":"Sample preparation for the HPLC analysis of drugs in biological fluids","volume":"7","author":"McDowall","year":"1989","journal-title":"J. Pharm. Anal."},{"key":"10.1016\/j.talanta.2020.121862_bib56","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jchromb.2003.11.043","article-title":"Restricted access materials and large particle supports for on-line sample preparation\u00a0: an attractive approach for biological fluids analysis","volume":"801","author":"Souverain","year":"2004","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.talanta.2020.121862_bib57","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jchromb.2007.12.012","article-title":"A fully automated plasma protein precipitation sample preparation method for LC \u2013 MS\/MS bioanalysis","volume":"862","author":"Ma","year":"2008","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.talanta.2020.121862_bib58","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jpba.2017.02.002","article-title":"UPLC\u2013MS\/MS method for the simultaneous quantification of three new antiretroviral drugs, dolutegravir, elvitegravir and rilpivirine, and other thirteen antiretroviral agents plus cobicistat and ritonavir boosters in human plasma","volume":"138","author":"Simiele","year":"2017","journal-title":"J. Pharmaceut. Biomed. Anal."},{"key":"10.1016\/j.talanta.2020.121862_bib59","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jpba.2013.08.002","article-title":"Validation of a fast method for quantitative analysis of elvitegravir, raltegravir, maraviroc, etravirine, tenofovir, boceprevir and 10 other antiretroviral agents in human plasma samples with a new UPLC-MS\/MS technology","volume":"86","author":"Djerada","year":"2013","journal-title":"J. Pharmaceut. Biomed. Anal."},{"key":"10.1016\/j.talanta.2020.121862_bib60","first-page":"127","article-title":"Desarrollo y validaci\u00f3n de un m\u00e9todo para la determinaci\u00f3n de darunavir en plasma mediante LC-MS\/MS","volume":"4","author":"Pajares Garc\u00eda","year":"2011","journal-title":"Rev. Del Lab. Clin."},{"key":"10.1016\/j.talanta.2020.121862_bib61","series-title":"Metabolism & Clinical Pharmacology of Antiretroviral Drugs","author":"Ter Heine","year":"2009"},{"key":"10.1016\/j.talanta.2020.121862_bib62","first-page":"1","article-title":"Development and validation of a UHPLC-MS\/MS method for quantification of the prodrug remdesivir and its metabolite GS-441524: a tool for clinical pharmacokinetics of SARS-CoV-2\/COVID-19 and Ebola virus disease","author":"Avataneo","year":"2020","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.talanta.2020.121862_bib63","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/j.jchromb.2010.03.036","article-title":"Validation of a rapid and sensitive high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS\/MS) assay for the simultaneous determination of existing and new antiretroviral compounds","volume":"878","author":"Else","year":"2010","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.talanta.2020.121862_bib64","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.jpba.2015.06.005","article-title":"Determination of abacavir, tenofovir, darunavir, and raltegravir in human plasma and saliva using liquid chromatography coupled with tandem mass spectrometry","volume":"114","author":"Yamada","year":"2015","journal-title":"J. Pharmaceut. Biomed. Anal."},{"key":"10.1016\/j.talanta.2020.121862_bib65","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1007\/s00216-016-9483-2","article-title":"In vitro and in vivo stability of oseltamivir within a bioequivalence trial","author":"Grigoriev","year":"2016","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.talanta.2020.121862_bib66","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jchromb.2012.02.026","article-title":"Quantitative determination of oseltamivir and oseltamivir carboxylate in human fluoride EDTA plasma including the ex vivo stability using high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry","author":"Kromdijk","year":"2012","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 891\u2013892"},{"key":"10.1016\/j.talanta.2020.121862_bib67","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.clinms.2018.04.001","article-title":"Determination of nucleosidic\/tidic reverse transcriptase inhibitors in plasma and cerebrospinal fluid by ultra-high-pressure liquid chromatography coupled with tandem mass spectrometry","volume":"8","author":"Courlet","year":"2018","journal-title":"Clin. Mass Spectrom."},{"key":"10.1016\/j.talanta.2020.121862_bib68","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jpba.2017.08.028","article-title":"Simultaneous determination of tenofovir alafenamide and its active metabolites tenofovir and tenofovir diphosphate in HBV-infected hepatocyte with a sensitive LC\u2013MS\/MS method","volume":"146","author":"Ouyang","year":"2017","journal-title":"J. Pharmaceut. Biomed. Anal."},{"key":"10.1016\/j.talanta.2020.121862_bib69","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jpba.2016.12.028","article-title":"Development and validation of a liquid chromatography-MS\/MS method for simultaneous quantification of tenofovir and efavirenz in biological tissues and fluids","volume":"136","author":"Barreiros","year":"2017","journal-title":"J. Pharmaceut. Biomed. Anal."},{"key":"10.1016\/j.talanta.2020.121862_bib70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0191236","article-title":"Simultaneous quantification of four antiretroviral drugs in breast milk samples from HIV-positive women by an ultra-high performance liquid chromatography tandem mass spectrometry (UPLC-MS\/MS) method","volume":"13","author":"Ram\u00edrez-Ram\u00edrez","year":"2018","journal-title":"PloS One"},{"key":"10.1016\/j.talanta.2020.121862_bib71","first-page":"913","article-title":"Protein precipitation for the analysis of a drug cocktail in plasma by LC \u2013 ESI \u2013","volume":"35","author":"Souverain","year":"2004","journal-title":"MS"},{"key":"10.1016\/j.talanta.2020.121862_bib72","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1016\/j.jchromb.2009.01.003","article-title":"Validation of bioanalytical LC-MS\/MS assays: evaluation of matrix effects","volume":"877","author":"Van Eeckhaut","year":"2009","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.talanta.2020.121862_bib73","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.jpha.2016.05.008","article-title":"Development of an HPLC\u2013UV assay method for the simultaneous quantification of nine antiretroviral agents in the plasma of HIV-infected patients","volume":"6","author":"Charbe","year":"2016","journal-title":"J. Pharm. Anal."},{"key":"10.1016\/j.talanta.2020.121862_bib74","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S0165-9936(03)00605-8","article-title":"New trends in solid-phase extraction","volume":"22","author":"Poole","year":"2003","journal-title":"Trends Anal. Chem."},{"key":"10.1016\/j.talanta.2020.121862_bib75","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.jpba.2011.05.039","article-title":"Determination of nucleoside analog mono-, di-, and tri-phosphates in cellular matrix by solid phase extraction and ultra-sensitive LC-MS\/MS detection","volume":"56","author":"Bushman","year":"2011","journal-title":"J. Pharmaceut. Biomed. Anal."},{"key":"10.1016\/j.talanta.2020.121862_bib76","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1039\/C6AY02442D","article-title":"A method employing SPE, MRM LC-MS\/MS and a THF\u2013water solvent system for the simultaneous determination of five antiretroviral drugs in human blood plasma","volume":"9","author":"Jr","year":"2017","journal-title":"Anal. Methods."},{"key":"10.1016\/j.talanta.2020.121862_bib77","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/bmc.1509","article-title":"Development and validation of a high-throughput and robust LC-MS\/MS with electrospray ionization method for simultaneous quantitation of oseltamivir phosphate and its oseltamivir carboxylate metabolite in human plasma for pharmacokinetic studies","volume":"25","author":"Kanneti","year":"2011","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.talanta.2020.121862_bib78","first-page":"491","article-title":"Development and validation of LC-MS\/MS method for determination of Darunavir in human plasma for application of clinical pharmacokinetics","volume":"3","author":"Kanneti","year":"2011","journal-title":"Int. J. Pharm. Pharmaceut. Sci."},{"key":"10.1016\/j.talanta.2020.121862_bib79","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jchromb.2003.09.044","article-title":"Simple liquid chromatography method for the rapid simultaneous determination of prednisolone and cortisol in plasma and urine using hydrophilic lipophilic balanced solid phase extraction cartridges","volume":"798","author":"Aburuz","year":"2003","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.talanta.2020.121862_bib80","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S1570-0232(03)00252-6","article-title":"T echnique validation by liquid chromatography for the determination of acyclovir in plasma","volume":"791","author":"Fernandez","year":"2003","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.talanta.2020.121862_bib81","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1016\/j.jchromb.2011.08.036","article-title":"MCX based solid phase extraction combined with liquid chromatography tandem mass spectrometry for the simultaneous determination of 31 endocrine-disrupting compounds in surface water of Shanghai","volume":"879","author":"Zhang","year":"2011","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.talanta.2020.121862_bib82","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jchromb.2013.05.008","article-title":"High throughput LC-MS\/MS method for simultaneous determination of tenofovir, lamivudine and nevirapine in human plasma","volume":"931","author":"Valluru","year":"2013","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.talanta.2020.121862_bib83","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jpba.2018.04.035","article-title":"Development and validation of an LC\u2013MS\/MS assay for tenofovir and tenofovir alafenamide in human plasma and cerebrospinal fluid","volume":"156","author":"Ocque","year":"2018","journal-title":"J. Pharmaceut. Biomed. Anal."},{"key":"10.1016\/j.talanta.2020.121862_bib84","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1002\/jssc.201401461","article-title":"Simultaneous determination of antiviral drugs in chicken tissues by ultra high performance liquid chromatography with tandem mass spectrometry","volume":"38","author":"Liu","year":"2015","journal-title":"J. Separ. Sci."},{"key":"10.1016\/j.talanta.2020.121862_bib85","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1007\/s00216-011-5581-3","article-title":"Quantitative trace analysis of a broad range of antiviral drugs in poultry muscle using column-switch liquid chromatography coupled to tandem mass spectrometry","volume":"402","author":"Berendsen","year":"2012","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.talanta.2020.121862_bib86","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1016\/j.jchromb.2011.07.008","article-title":"Application of a validated ultra performance liquid chromatography-tandem mass spectrometry method for the quantification of darunavir in human plasma for a bioequivalence study in Indian subjects","volume":"879","author":"Gupta","year":"2011","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.talanta.2020.121862_bib87","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0731-7085(99)00247-2","article-title":"Semi-automated 96-well liquid-liquid extraction for quantitation of drugs in biological fluids","volume":"22","author":"Zhang","year":"2000","journal-title":"J. Pharmaceut. Biomed. Anal."},{"key":"10.1016\/j.talanta.2020.121862_bib88","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1093\/chromsci\/bmy002","article-title":"Drug-drug interactions between PA-824 and darunavir based on pharmacokinetics in rats by LC-MS-MS","volume":"56","author":"Wang","year":"2018","journal-title":"J. Chromatogr. Sci."},{"key":"10.1016\/j.talanta.2020.121862_bib89","doi-asserted-by":"crossref","first-page":"190","DOI":"10.13181\/mji.v20i3.449","article-title":"Primaquine decreased plasma concentration of ritonavir: single- and repeated-dose study in sprague dawley rats","volume":"20","author":"Louisa","year":"2011","journal-title":"Med. J. Indones."},{"key":"10.1016\/j.talanta.2020.121862_bib90","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.hivar.2013.10.002","article-title":"Interpatient variability of darunavir concentrations in plasma during long-term antiretroviral monotherapy","volume":"13","author":"Gralak-Dabrowska","year":"2014","journal-title":"HIV AIDS Rev"},{"key":"10.1016\/j.talanta.2020.121862_bib91","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/bmc.3021","article-title":"Combined quantification of paclitaxel, docetaxel and ritonavir in human feces and urine using LC-MS\/MS","volume":"28","author":"Hendrikx","year":"2014","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.talanta.2020.121862_bib92","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jchromb.2016.01.016","article-title":"Determination of ribavirin in chicken muscle by quick, easy, cheap, effective, rugged and safe method and liquid chromatography-tandem mass spectrometry","volume":"1012","author":"Wu","year":"2016","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.talanta.2020.121862_bib93","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.steroids.2010.04.007","article-title":"Analysis of anabolic steroids in human hair using LC-MS\/MS","volume":"75","author":"Deshmukh","year":"2010","journal-title":"Steroids"},{"key":"10.1016\/j.talanta.2020.121862_bib94","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.cca.2006.02.019","article-title":"State of the art in hair analysis for detection of drug and alcohol abuse","volume":"370","author":"Pragst","year":"2006","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.talanta.2020.121862_bib95","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.4155\/bio-2016-0040","article-title":"Development and validation of a UPLC-MS\/MS method for the simultaneous determination of paritaprevir and ritonavir in rat liver","volume":"8","author":"Ocque","year":"2016","journal-title":"Bioanalysis"},{"key":"10.1016\/j.talanta.2020.121862_bib96","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jchromb.2017.03.020","article-title":"Ultra-performance liquid chromatography tandem mass spectrometry for determination of Direct Acting Antiviral drugs in human liver fine needle aspirates","volume":"1052","author":"Ocque","year":"2017","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.talanta.2020.121862_bib97","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jchromb.2014.10.032","article-title":"Simultaneous determination of lopinavir and three ester prodrugs by LC-MS\/MS in lysates of BeWo cells","volume":"975","author":"Wang","year":"2015","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.talanta.2020.121862_bib98","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1093\/chromsci\/bmt147","article-title":"Determination of intracellular darunavir by liquid chromatography coupled with fluorescence detection","volume":"52","author":"Nagano","year":"2014","journal-title":"J. Chromatogr. Sci."},{"key":"10.1016\/j.talanta.2020.121862_bib99","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jpba.2013.11.027","article-title":"Development and validation of a useful UPLC-MS\/MS method for quantification of total and phosphorylated-ribavirin in peripheral blood mononuclear cells of HCV+ patients","volume":"90","author":"Agnesod","year":"2014","journal-title":"J. Pharmaceut. Biomed. Anal."},{"key":"10.1016\/j.talanta.2020.121862_bib100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vascn.2017.10.001","article-title":"Comparison of efficiencies of selected sample extraction techniques for the analysis of selected antiretroviral drugs in human plasma using LC-MS","volume":"89","author":"Sichilongo","year":"2018","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.talanta.2020.121862_bib101","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1515\/chem-2015-0109","article-title":"A review of recent developments and trends in the QuEChERS sample preparation approach","volume":"13","author":"Rejczak","year":"2015","journal-title":"Open Chem"},{"key":"10.1016\/j.talanta.2020.121862_bib102","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/jaoac\/86.2.412","article-title":"Fast and easy multiresidue method employing acetonitrile extraction\/partitioning and \u201cdispersive solid-phase extraction\u201d for the determination of pesticide residues in produce","volume":"86","author":"Anastassiades Michelangelo","year":"2003","journal-title":"J. AOAC Int."},{"key":"10.1016\/j.talanta.2020.121862_bib103","series-title":"LC\/MS Based Food Metabolomics","author":"Pascale","year":"2020"},{"key":"10.1016\/j.talanta.2020.121862_bib104","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jchromb.2004.10.049","article-title":"Simple and cost-effective liquid chromatographic method for determination of pyrimethamine in whole blood samples dried on filter paper","volume":"814","author":"Minzi","year":"2005","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.talanta.2020.121862_bib105","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1093\/jn\/131.5.1631S","article-title":"Innovative non- or minimally-invasive technologies for monitoring Health and nutritional status in mothers and young children use of filter paper for the collection and analysis of human whole blood specimens 1","volume":"131","author":"V Mei","year":"2001","journal-title":"J. Nutr."},{"key":"10.1016\/j.talanta.2020.121862_bib106","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/annotation\/9e6e8b98-cc08-47be-9ab1-3f1928e12fed","article-title":"Ultra-fast analysis of plasma and intracellular levels of HIV protease inhibitors in children: a clinical application of MALDI mass spectrometry","volume":"5","author":"van Kampen","year":"2010","journal-title":"PloS One"},{"key":"10.1016\/j.talanta.2020.121862_bib107","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/jms.1897","article-title":"Determination of the antiretroviral drug tenofovir in plasma from HIV-infected adults by ultrafast isotope dilution MALDI-triple quadrupole tandem mass spectrometry","volume":"46","author":"Meesters","year":"2011","journal-title":"J. Mass Spectrom."},{"key":"10.1016\/j.talanta.2020.121862_bib108","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1007\/s00216-014-8220-y","article-title":"Quantitative mass spectrometry imaging of emtricitabine in cervical tissue model using infrared matrix-assisted laser desorption electrospray ionization","volume":"407","author":"Bokhart","year":"2015","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.talanta.2020.121862_bib109","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.xphs.2017.05.016","article-title":"Using potentiometric free drug sensors to determine the free concentration of ionizable drugs in colloidal systems","volume":"107","author":"Tran","year":"2018","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.talanta.2020.121862_bib110","doi-asserted-by":"crossref","first-page":"365","DOI":"10.2116\/analsci.25.365","article-title":"Sulfadiazine-potentiometric sensors for flow and batch determinations of sulfadiazine in drugs and biological fluids","volume":"25","author":"Kamel","year":"2009","journal-title":"Anal. Sci."},{"key":"10.1016\/j.talanta.2020.121862_bib111","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.trac.2005.01.003","article-title":"Potentiometric sensors for trace-level analysis","volume":"24","author":"Bakker","year":"2005","journal-title":"TrAC Trends Anal. Chem. (Reference Ed.)"},{"key":"10.1016\/j.talanta.2020.121862_bib112","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.arabjc.2010.12.006","article-title":"Spectrophotometric and spectrofluorometric methods for the determination of non-steroidal anti-inflammatory drugs: a review","volume":"6","author":"Gouda","year":"2013","journal-title":"Arab. J. Chem."},{"key":"10.1016\/j.talanta.2020.121862_bib113","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S0731-7085(99)00088-6","article-title":"Capillary electrophoresis as a versatile tool for the bioanalysis of drugs - a review","volume":"20","author":"Boone","year":"1999","journal-title":"J. Pharmaceut. Biomed. Anal."},{"key":"10.1016\/j.talanta.2020.121862_bib114","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1093\/chromsci\/bmz038","article-title":"Validated RP-HPLC method for simultaneous determination of ribavirin, sofosbuvir and daclatasvir in human plasma: a treatment protocol administered to HCV patients in Egypt","volume":"57","author":"Youssef","year":"2019","journal-title":"J. Chromatogr. Sci."},{"key":"10.1016\/j.talanta.2020.121862_bib115","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.13005\/ojc\/330528","article-title":"New analytical HPLC method development and validation for the simultaneous quantification of paritaprevir ombitasvir and ritonavirin spiked human plasma","volume":"33","author":"Phani","year":"2017","journal-title":"Orient. J. Chem."},{"key":"10.1016\/j.talanta.2020.121862_bib116","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1556\/AChrom.27.2015.4.2","article-title":"A simple liquid chromatographic method for the determination of tenofovir in rat plasma and its application to pharmacokinetic studies","volume":"27","author":"Ravi","year":"2015","journal-title":"Acta Chromatogr."},{"key":"10.1016\/j.talanta.2020.121862_bib117","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.jpba.2012.03.030","article-title":"Development and validation of a useful HPLC-UV method for quantification of total and phosphorylated-ribavirin in blood and erythrocytes of HCV+ patients","volume":"66","author":"D'Avolio","year":"2012","journal-title":"J. Pharmaceut. Biomed. Anal."},{"key":"10.1016\/j.talanta.2020.121862_bib118","first-page":"1626","article-title":"Validated RP-HPLC method development for estimation of Tenofovir Disoproxil Fumarate from plasma","volume":"4","author":"Sutar","year":"2011","journal-title":"Res. J. Pharm. Technol."},{"key":"10.1016\/j.talanta.2020.121862_bib119","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1089\/aid.2009.0154","article-title":"Age-related changes in plasma concentrations of the HIV protease inhibitor lopinavir","volume":"26","author":"Crawford","year":"2010","journal-title":"AIDS Res. Hum. Retrovir."},{"key":"10.1016\/j.talanta.2020.121862_bib120","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.chroma.2018.01.014","article-title":"Impurity profiling of drug candidates: analytical strategies using reversed-phase and mixed-mode high-performance liquid chromatography methods","volume":"1535","author":"Lemasson","year":"2018","journal-title":"J. Chromatogr., A"},{"key":"10.1016\/j.talanta.2020.121862_bib121","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0378-4347(01)00379-6","article-title":"Separation methods for acyclovir and related antiviral compounds","volume":"764","author":"Loregian","year":"2001","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.talanta.2020.121862_bib122","doi-asserted-by":"crossref","first-page":"833","DOI":"10.3109\/03639049509026647","article-title":"Effect of mobile phase pH on the separation of drugs using high-performance liquid chromatography","volume":"21","author":"Das Gupta","year":"1995","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.talanta.2020.121862_bib123","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pharmaceutics10040221","article-title":"A review on liquid chromatography-tandem mass spectrometry methods for rapid quantification of oncology drugs","volume":"10","author":"Wong","year":"2018","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.talanta.2020.121862_bib124","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1002\/jssc.201400574","article-title":"Use of micellar liquid chromatography to analyze darunavir , ritonavir , emtricitabine , and tenofovir in plasma","author":"Peris-vicente","year":"2014","journal-title":"J. Separ. Sci."},{"key":"10.1016\/j.talanta.2020.121862_bib125","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1021\/ac00285a015","article-title":"Direct serum injection with micellar liquid chromatography for therapeutic drug monitoring","volume":"57","author":"DeLuccia","year":"1985","journal-title":"Anal. Chem."},{"key":"10.1016\/j.talanta.2020.121862_bib126","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1365\/s10337-008-0871-4","article-title":"Development of a sensitive LC assay with fluorescence detection for the determination of zearalenone in rat serum","volume":"69","author":"Shin","year":"2009","journal-title":"Chromatographia"},{"key":"10.1016\/j.talanta.2020.121862_bib127","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1002\/jms.1799","article-title":"Polybrominated diphenyl ethers (PBDEs) in Mediterranean mussels (Mytilus galloprovincialis) from selected Apulia coastal sites evaluated by GC-HRMS","volume":"45","author":"Bianco","year":"2010","journal-title":"J. Mass Spectrom."},{"key":"10.1016\/j.talanta.2020.121862_bib128","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1007\/s00216-017-0806-8","article-title":"Determination of soyasaponins in Fagioli di Sarconi beans (Phaseolus vulgaris L.) by LC-ESI-FTICR-MS and evaluation of their hypoglycemic activity","volume":"410","author":"Bianco","year":"2018","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.talanta.2020.121862_bib129","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00216-002-1321-z","article-title":"Small molecule analysis by MALDI mass spectrometry","author":"Cohen","year":"2002","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.talanta.2020.121862_bib130","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1002\/jssc.201900509","article-title":"Validation of a liquid chromatography coupled with tandem mass spectrometry method for the determination of drugs in wastewater using a three-phase solvent system","volume":"43","author":"Pascale","year":"2020","journal-title":"J. Separ. Sci."},{"key":"10.1016\/j.talanta.2020.121862_bib131","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.vascn.2006.11.004","article-title":"Utility of imaging mass spectrometry (IMS) by matrix-assisted laser desorption ionization (MALDI) on an ion trap mass spectrometer in the analysis of drugs and metabolites in biological tissues","volume":"55","author":"Drexler","year":"2007","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.talanta.2020.121862_bib132","doi-asserted-by":"crossref","first-page":"5665","DOI":"10.1021\/acs.analchem.7b00096","article-title":"Think negative: finding the best electrospray ionization\/MS mode for your analyte","volume":"89","author":"Liigand","year":"2017","journal-title":"Anal. Chem."},{"key":"10.1016\/j.talanta.2020.121862_bib133","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/aocs.12072","article-title":"Investigation of the effects of virgin olive oil cleaning systems on the secoiridoid aglycone content using high performance liquid chromatography\u2013mass spectrometry","volume":"95","author":"Pascale","year":"2018","journal-title":"JAOCS, J. Am. Oil Chem. Soc."},{"key":"10.1016\/j.talanta.2020.121862_bib134","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1080\/05704920902717872","article-title":"Mass spectrometry, review of the basics: electrospray, MALDI, and commonly used mass analyzers","volume":"44","author":"El-Aneed","year":"2009","journal-title":"Appl. Spectrosc. Rev."},{"key":"10.1016\/j.talanta.2020.121862_bib135","first-page":"19","article-title":"Principles and applications of liquid chromatography-mass spectrometry in clinical biochemistry","volume":"30","author":"Pitt","year":"2009","journal-title":"Clin. Biochem. Rev."},{"key":"10.1016\/j.talanta.2020.121862_bib136","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/rcm.6461","article-title":"High-throughput liquid chromatography\/mass spectrometry method for the quantitation of small molecules using accurate mass technologies in supporting discovery drug screening","volume":"27","author":"Ding","year":"2013","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.talanta.2020.121862_bib137","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1002\/jms.207","article-title":"An introduction to quadrupole-time-of-flight mass spectrometry","volume":"36","author":"Chernushevich","year":"2001","journal-title":"J. Mass Spectrom."},{"key":"10.1016\/j.talanta.2020.121862_bib138","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/chromsci\/bms048","article-title":"Simultaneous quantitation of HIV-protease inhibitors ritonavir, lopinavir and indinavir in human plasma by UPLC-ESI-MS-MS","volume":"50","author":"Das Mishra","year":"2012","journal-title":"J. Chromatogr. Sci."},{"key":"10.1016\/j.talanta.2020.121862_bib139","first-page":"1","article-title":"Tandem mass spectrometry of small-molecule antiviral drugs: 3. antiviral agents against herpes, influenza and other viral infections","volume":"455","author":"Niessen","year":"2020","journal-title":"Int. J. Mass Spectrom."},{"key":"10.1016\/j.talanta.2020.121862_bib140","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1093\/chromsci\/48.9.704","article-title":"Selective determination of antiretroviral agents tenofovir, emtricitabine, and lamivudine in human plasma by a LC-MS-MS method for a bioequivalence study in healthy Indian subjects","volume":"48","author":"Yadav","year":"2010","journal-title":"J. Chromatogr. Sci."},{"key":"10.1016\/j.talanta.2020.121862_bib141","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1570-0232(02)00379-3","article-title":"Specific, sensitive and accurate liquid chromatographic-tandem mass spectrometric method for the measurement of ribavirin in rat and monkey plasma","volume":"779","author":"Lin","year":"2002","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.talanta.2020.121862_bib142","first-page":"1515","article-title":"Standard definitions of terms related to mass spectrometry","volume":"26","author":"Murray","year":"2014","journal-title":"Chem. Int. -- Newsmag. IUPAC."},{"key":"10.1016\/j.talanta.2020.121862_bib143","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.aca.2015.02.017","article-title":"Tutorial review on validation of liquid chromatography-mass spectrometry methods: Part I","volume":"870","author":"Kruve","year":"2015","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.talanta.2020.121862_bib144","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1007\/s00216-014-8315-5","article-title":"Quantification in MALDI-MS imaging: what can we learn from MALDI-selected reaction monitoring and what can we expect for imaging?","volume":"407","author":"Porta","year":"2015","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.talanta.2020.121862_bib145","doi-asserted-by":"crossref","first-page":"5757","DOI":"10.1039\/c2an35782h","article-title":"A new combination MALDI matrix for small molecule analysis: application to imaging mass spectrometry for drugs and metabolites","volume":"137","author":"Shanta","year":"2012","journal-title":"Analyst"},{"key":"10.1016\/j.talanta.2020.121862_bib146","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s13361-013-0787-6","article-title":"IR-MALDESI mass spectrometry imaging of biological tissue sections using ice as a matrix","volume":"25","author":"Robichaud","year":"2014","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"10.1016\/j.talanta.2020.121862_bib147","first-page":"417","article-title":"Validation of liquid chromatography-tandem mass spectrometric method for simultaneous determination of lopinavir and ritonavir in human plasma, and its application in a bioequivalescence study in Thai volunteers","volume":"29","author":"Bhuket","year":"2015","journal-title":"J. Heal. Res."},{"key":"10.1016\/j.talanta.2020.121862_bib148","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/jssc.201301173","article-title":"Quantitation of ribavirin in human plasma and red blood cells using LC \u2013 MS\/MS","author":"Ferreiros","year":"2014","journal-title":"J. Separ. Sci."},{"key":"10.1016\/j.talanta.2020.121862_bib149","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1002\/jssc.201801060","article-title":"Effect of pH and mobile phase additives on the chromatographic behaviour of an amide-embedded stationary phase: cyanocobalamin and its diaminemonochloro-platinum(II) conjugate as a case study","volume":"42","author":"Ventura","year":"2019","journal-title":"J. Separ. Sci."},{"key":"10.1016\/j.talanta.2020.121862_bib150","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jpba.2011.10.021","article-title":"Comprehensive investigation of the influence of acidic, basic, and organic mobile phase compositions on bioanalytical assay sensitivity in positive ESI mode LC\/MS\/MS","volume":"59","author":"Rainville","year":"2012","journal-title":"J. Pharmaceut. Biomed. Anal."},{"key":"10.1016\/j.talanta.2020.121862_bib151","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/S1044-0305(03)00574-9","article-title":"Matrix effect in bio-analysis of illicit drugs with LC-MS\/MS: influence of ionization type, sample preparation, and biofluid","volume":"14","author":"Dams","year":"2003","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"10.1016\/j.talanta.2020.121862_bib152","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/rcm.876","article-title":"Investigation of matrix effects in bioanalytical high-performance liquid chromatography\/tandem mass spectrometric assays: application to drug discovery","volume":"17","author":"Mei","year":"2003","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.talanta.2020.121862_bib153","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.trac.2014.08.007","article-title":"Current and future trends in UHPLC","volume":"63","author":"Fekete","year":"2014","journal-title":"TrAC Trends Anal. Chem. (Reference Ed.)"},{"key":"10.1016\/j.talanta.2020.121862_bib154","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s13318-019-00584-6","article-title":"Development and validation of a new LC\u2013MS\/MS analytical method for direct-acting antivirals and its application in end-stage renal disease patients","volume":"45","author":"Farouk","year":"2020","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.talanta.2020.121862_bib155","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.jpba.2018.02.011","article-title":"Validation and implementation of liquid chromatographic-mass spectrometric (LC\u2013MS) methods for the quantification of tenofovir prodrugs","volume":"152","author":"Hummert","year":"2018","journal-title":"J. Pharmaceut. Biomed. Anal."},{"key":"10.1016\/j.talanta.2020.121862_bib156","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jchromb.2018.03.021","article-title":"Simultaneous determination of antiretroviral drugs in human hair with liquid chromatography-electrospray ionization-tandem mass spectrometry","volume":"1083","author":"Wu","year":"2018","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.talanta.2020.121862_bib157","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.jpba.2016.07.040","article-title":"Simultaneous quantification of tenofovir, emtricitabine, rilpivirine, elvitegravir and dolutegravir in mouse biological matrices by LC\u2013MS\/MS and its application to a pharmacokinetic study","volume":"129","author":"Prathipati","year":"2016","journal-title":"J. Pharmaceut. Biomed. Anal."},{"key":"10.1016\/j.talanta.2020.121862_bib158","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jchromb.2016.04.019","article-title":"Simultaneous determination of pradefovir, PMEA and tenofovir in HBV patient serum using liquid chromatography-tandem mass spectrometry and application to phase 2 clinical trial","volume":"1022","author":"Xiao","year":"2016","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.talanta.2020.121862_bib159","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1002\/jssc.201500250","article-title":"Development and validation of a rapid ultra high performance liquid chromatography with tandem mass spectrometry method for the simultaneous determination of darunavir, ritonavir, and tenofovir in human plasma: application to human pharmacokinetics","volume":"38","author":"Reddy","year":"2015","journal-title":"J. Separ. Sci."},{"key":"10.1016\/j.talanta.2020.121862_bib160","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jchromb.2015.08.038","article-title":"Evaluation of a rapid method for the simultaneous quantification of ribavirin, sofosbuvir and its metabolite in rat plasma by UPLC-MS\/MS","volume":"1002","author":"Shi","year":"2015","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.talanta.2020.121862_bib161","first-page":"1","article-title":"Validation of simultaneous quantitative method of HIV protease inhibitors atazanavir, darunavir and ritonavir in human plasma by UPLC-MS\/MS","volume":"2014","author":"Mishra","year":"2014","journal-title":"Sci. World J."},{"key":"10.1016\/j.talanta.2020.121862_bib162","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1002\/bmc.2679","article-title":"A novel LC-MS\/MS method for simultaneous quantification of tenofovir and lamivudine in human plasma and its application to a pharmacokinetic study","volume":"26","author":"Matta","year":"2012","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.talanta.2020.121862_bib163","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1016\/j.cca.2011.07.016","article-title":"LC-MS\/MS quantitation of ribavirin in serum and identification of endogenous isobaric interferences","volume":"412","author":"Danso","year":"2011","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.talanta.2020.121862_bib164","first-page":"877","article-title":"Development and validation of an LC\/MS\/MS method for the determination of tenofovir in monkey","volume":"34","author":"Uo","year":"2011","journal-title":"Plasma"},{"key":"10.1016\/j.talanta.2020.121862_bib165","doi-asserted-by":"crossref","first-page":"849","DOI":"10.3797\/scipharm.1107-24","article-title":"Simple, rapid and validated LC determination of lopinavir in rat plasma and its application in pharmacokinetic studies","volume":"79","author":"Vats","year":"2011","journal-title":"Sci. Pharm."},{"key":"10.1016\/j.talanta.2020.121862_bib166","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/chromsci\/48.3.219","article-title":"Development of an LC-MS method for measuring TNF in human vaginal tissue","volume":"48","author":"Choi","year":"2010","journal-title":"J. Chromatogr. Sci."},{"key":"10.1016\/j.talanta.2020.121862_bib167","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1365\/s10337-010-1550-9","article-title":"Simultaneous determination of ritonavir and lopinavir in human plasma after protein precipitation and LC-MS-MS","volume":"71","author":"Damaramadugu","year":"2010","journal-title":"Chromatographia"},{"key":"10.1016\/j.talanta.2020.121862_bib168","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.jchromb.2010.01.002","article-title":"Simultaneous quantification of emtricitabine and tenofovir nucleotides in peripheral blood mononuclear cells using weak anion-exchange liquid chromatography coupled with tandem mass spectrometry","volume":"878","author":"Jansen","year":"2010","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."}],"container-title":["Talanta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003991402031153X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003991402031153X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T12:52:43Z","timestamp":1758545563000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S003991402031153X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":168,"alternative-id":["S003991402031153X"],"URL":"https:\/\/doi.org\/10.1016\/j.talanta.2020.121862","relation":{"has-review":[{"id-type":"doi","id":"10.32388\/G67RJL","asserted-by":"object"}]},"ISSN":["0039-9140"],"issn-type":[{"value":"0039-9140","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Detection and quantification of Covid-19 antiviral drugs in biological fluids and tissues","name":"articletitle","label":"Article Title"},{"value":"Talanta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.talanta.2020.121862","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"121862"}}